The Double Burden of the COVID-19 Pandemic and Polypharmacy on Geriatric Population – Public Health Implications

References

• O’Mara G. Could ACE inhibitors and particularly ARBs increase susceptibility to COVID-19 infection? BMJ. 2020;368:m406.
   PubMedGoogle Scholar
• Nobili A, Garattini S, Mannucci PM. Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium. J Comorb. 2011;1:28–44. doi:10.15256/joc.2011.1.4
   PubMedGoogle Scholar
• Prithviraj GK, Koroukian S, Margevicius S, Berger NA, Bagai R, Owusu C. Patient characteristics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer. J Geriatr Oncol. 2012;3(3):228–237. doi:10.1016/j.jgo.2012.02.005
   PubMed Web of Science ®Google Scholar
• Zelko E, Klemenc-Ketis Z, Tusek-Bunc K. Medication adherence in elderly with polypharmacy living at home: a systematic review of existing studies. Mater Sociomed. 2016;28(2):129–132. doi:doi.10.5455/msm.2016.28.129-132.
   PubMedGoogle Scholar
• Herr M, Sirven N, Grondin H, Pichetti S, Sermet C. Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French population. Eur J Clin Pharmacol. 2017;73(9):1165–1172. doi:10.1007/s00228-017-2276-5.
   PubMed Web of Science ®Google Scholar
• Stocks SJ, Kontopantelis E, Akbarov A, Rodgers S, Avery AJ, Ashcroft DM. Examining variations in prescribing safety in UK general practice: cross-sectional study using the clinical practice research datalink. BMJ. 2015;351:h5501. doi:10.1136/bmj.h5501
   PubMed Web of Science ®Google Scholar
• Hanlon P, Nicholl BI, Jani BD, et al. Examining patterns of multimorbidity, polypharmacy, and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study. BMJ Open. 2018;8(1):e018404. doi:10.1136/bmjopen-2017-018404
   PubMed Web of Science ®Google Scholar
• Dookeeram D, Bidaisee S, Paul JF, et al. Polypharmacy and potential drug-drug interactions in emergency department patients in the Caribbean. Int J Clin Pharm. 2017;39(5):1119‐27. doi:10.1007/s11096-017-0520-9
   PubMed Web of Science ®Google Scholar
• Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in prescription drug use among adults in the United States from 19992012. JAMA. 2015;314(17):1818–1831. doi:10.1001/jama.2015.13766
   PubMed Web of Science ®Google Scholar
• Hovstadius B, Hovstadius K, Astrand B, Petersson G. Increasing polypharmacy - an individual-based study of the Swedish population 20052008. BMC Clin Pharmacol. 2010;10:16. doi:10.1186/1472-6904-10-16
   PubMedGoogle Scholar
• Bushardt RL, Massey EB, Simpson TW, Ariail JC, Simpson KN. Polypharmacy: misleading, but manageable. Clin Interv Aging. 2008;3(2):383–389. doi:10.2147/cia.s2468
   PubMed Web of Science ®Google Scholar
• Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230. doi:10.1186/s12877-017-0621-2
   PubMed Web of Science ®Google Scholar
• Duerden M, Avery T, Payne R Polypharmacy and medicines optimization: making it safe and sound. London: the King’s Fund; 2013. Available from http://www.volgmed.ru/uploads/files/2014-12/35099-prilozhenie_1-3_k_informacionnomu_pismu_2.pdf. [Accessed September 10, 2020.]
   Google Scholar
• Friend DG. Polypharmacy; multiple-ingredient and shotgun prescriptions. N Engl J Med. 1959;260(20):1015–1018. doi:10.1056/NEJM195905142602005
   PubMed Web of Science ®Google Scholar
• De Las Cuevas C, Sanz EJ. Polypharmacy in psychiatric practice in the Canary Islands. BMC Psychiatry. 2004;4:18. doi:10.1186/1471-244X-4-18
   PubMed Web of Science ®Google Scholar
• Riker GI, Setter SM. Polypharmacy in older adults at home: what it is and what to do about it–implications for home healthcare and hospice. Home Healthc Nurse. 2012;30(8):474–487. doi:10.1097/NHH.0b013e31826502dd
   PubMedGoogle Scholar
• Guthrie B, Makubate B, Hernandez-Santiago V, Dreischulte T. The rising tide of polypharmacy and drug-drug interactions: population database analysis 19952010. BMC Med. 2015;13:74. doi:10.1186/s12916-015-0322-7
   PubMed Web of Science ®Google Scholar
• Walckiers D, Van der Heyden J, Tafforeau J. Factors associated with excessive polypharmacy in older people. Arch Public Health. 2015;73:50. doi:10.1186/s13690-015-0095-7
   PubMedGoogle Scholar
• Moriarty F, Hardy C, Bennett K, Smith SM, Fahey T. Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study. BMJ Open. 2015;5(9):e008656. doi:10.1136/bmjopen-2015-008656
   PubMed Web of Science ®Google Scholar
• Ong SM, Lim YMF, Sivasampu S, Khoo EM. Variation of polypharmacy in older primary care attenders occurs at the prescriber level. BMC Geriatr. 2018;18(1):59. doi:10.1186/s12877-018-0750-2
   PubMed Web of Science ®Google Scholar
• Beuscart JB, Petit S, Gautier S, et al. Polypharmacy in older patients: identifying the need for support by a community pharmacist. BMC Geriatr. 2019;19(1):277. doi:10.1186/s12877-019-1276-y
   PubMed Web of Science ®Google Scholar
• Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345–351. doi:10.1016/j.amjopharm.2007.12.002
   PubMedGoogle Scholar
• Aronson JK. Polypharmacy, appropriate, and inappropriate. Br J Gen Pract. 2006;56(528):484–485.
   PubMed Web of Science ®Google Scholar
• Aronson JK. In defense of polypharmacy. Br J Clin Pharmacol. 2004;57:119–120. doi:10.1111/j.1365-2125.2004.02067.x
   PubMed Web of Science ®Google Scholar
• Aronson JK. Rational prescribing, appropriate prescribing. Br J Clin Pharmacol. 2004;57:229–230. doi:10.1111/j.1365-2125.2004.02090.x
   PubMed Web of Science ®Google Scholar
• Dagli RJ, Sharma A. Polypharmacy: a global risk factor for elderly people. J Int Oral Health. 2014;6(6):i–ii.
   Google Scholar
• Molokhia M, Majeed A. Current and future perspectives on the management of polypharmacy. BMC Fam Pract. 2017;18(1):70. doi:10.1186/s12875-017-0642-0
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Valencia M, Izquierdo M, Cesari M, Casas-Herrero Á, Inzitari M, Martínez-Velilla N. The relationship between frailty and polypharmacy in older people: A systematic review. Br J Clin Pharmacol. 2018;84(7):1432–1444. doi:10.1111/bcp.13590
   PubMed Web of Science ®Google Scholar
• Porter B, Arthur A, Savva GM. How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study. BMJ Open. 2019;9(5):e026171. doi:10.1136/bmjopen-2018-026171
   PubMed Web of Science ®Google Scholar
• Kwan D, Farrell B. Polypharmacy: optimizing medication use in elderly patients. Can Geriatr J. 2014;4(1):21–27.
   Google Scholar
• Pappa E, Kontodimopoulos N, Papadopoulos AA, Tountas Y, Niakas D. Prescribed-drug utilization and polypharmacy in a general population in Greece: association with sociodemographic, health needs, health-services utilization, and lifestyle factors. Eur J Clin Pharmacol. 2011;67(2):185–192. doi:10.1007/s00228-010-0940-0
   PubMed Web of Science ®Google Scholar
• Charlesworth CJ, Smit E, Lee DS, Alramadhan F, Odden MC. Polypharmacy Among Adults Aged 65 Years and Older in the United States: 19882010. J Gerontol, a Biol Sci Med Sci. 2015;70(8):989–995. doi:10.1093/gerona/glv013
   PubMed Web of Science ®Google Scholar
• Wong H, Heuberger R, Logomarsino J, Hewlings S. Associations between alcohol use, polypharmacy, and falls in older adults. Nurs Older People. 2016;28(1):30–36.
   PubMedGoogle Scholar
• Hovstadius B, Petersson G. Factors leading to excessive polypharmacy. Clin Geriatr Med. 2012;28(2):159–172. doi:10.1016/j.cger.2012.01.001
   PubMed Web of Science ®Google Scholar
• Carmona-Torres JM, Cobo-Cuenca AI, Recio-Andrade B, Laredo-Aguilera JA, Martins MM, Rodríguez-Borrego MA. Prevalence and factors associated with polypharmacy in the older people: 20062014. J Clin Nurs. 2018;27(1516):2942–2952. doi:10.1111/jocn.14371
   PubMed Web of Science ®Google Scholar
• Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65. doi:10.1517/14740338.2013.827660
   PubMed Web of Science ®Google Scholar
• Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K. Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol. 2010;69(5):543–552. doi:10.1111/j.1365-2125.2010.03628.x
   PubMed Web of Science ®Google Scholar
• Bradley MC, Fahey T, Cahir C, et al. Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database. Eur J Clin Pharmacol. 2012;68(10):1425–1433. doi:10.1007/s00228-012-1249-y
   PubMed Web of Science ®Google Scholar
• Aitken M, Gorokhovich L. Advancing the Responsible Use of Medicines: Applying Levers for Change. Parsippany (NJ): IMS Institute for Healthcare Informatics; 2012.
   Google Scholar
• Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827–834. doi:10.1001/jamainternmed.2015.0324
   PubMed Web of Science ®Google Scholar
• Wang R, Chen L, Fan L, et al. Incidence and effects of polypharmacy on clinical outcome among patients aged 80+: a five-year follow-up study. PLoS One. 2015;10(11):e0142123. doi:10.1371/journal.pone.0142123
   PubMed Web of Science ®Google Scholar
• Tiihonen J, Suokas JT, Suvisaari JM, Haukka J, Korhonen P. Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia. Arch Gen Psychiatry. 2012;69(5):476‐83. doi:10.1001/archgenpsychiatry.2011.1532
   PubMed Web of Science ®Google Scholar
• Tjia J, Velten SJ, Parsons C, Valluri S, Briesacher BA. Studies to reduce unnecessary medication use in frail older adults: a systematic review. Drugs Aging. 2013;30(5):285‐307. doi:10.1007/s40266-013-0064-1
   PubMed Web of Science ®Google Scholar
• Sönnichsen A, Trampisch US, Rieckert A, et al. Polypharmacy in chronic diseases-reduction of inappropriate medication and adverse drug events in older populations by electronic decision support (PRIMA-eDS): study protocol for a randomized controlled trial. Trials. 2016;17:57. doi:10.1186/s13063-016-1177-8
   PubMed Web of Science ®Google Scholar
• Uchida M, Suzuki S, Sugawara H, et al. A nationwide survey of hospital pharmacist interventions to improve polypharmacy for patients with cancer in palliative care in Japan. J Pharm Health Care Sci. 2019;5:14. doi:10.1186/s40780-019-0143-5
   PubMed Web of Science ®Google Scholar
• Alarcón T, Bárcena A, González-Montalvo JI, Penãlosa C, Salgado A. Factors predictive of outcome on admission to an acute geriatric ward. Age Ageing. 1999;28(5):429‐32. doi:10.1093/ageing/28.5.429
   PubMed Web of Science ®Google Scholar
• Unutmaz GD, Soysal P, Tuven B, Isik AT. Costs of medication in older patients: before and after comprehensive geriatric assessment. Clin Interv Aging. 2018;13:607‐13. doi:10.2147/CIA.S159966
   PubMed Web of Science ®Google Scholar
• Flaherty JH, Perry HM 3rd, Lynchard GS, Morley JE. Polypharmacy and hospitalization among older home care patients. J Gerontol a Biol Sci Med Sci. 2000;55(10):M554–M559. doi:10.1093/gerona/55.10.m554
   PubMed Web of Science ®Google Scholar
• Franchi C, Marcucci M, Mannucci PM, et al. Changes in clinical outcomes for community-dwelling older people exposed to incident chronic polypharmacy: a comparison between 2001 and 2009. Pharmacoepidemiol Drug Saf. 2016;25(2):204–211. doi:10.1002/pds.3938
   PubMed Web of Science ®Google Scholar
• Alsuwaidan A, Almedlej N, Alsabti S, et al. A comprehensive overview of polypharmacy in elderly patients in Saudi Arabia. Geriatrics. 2019;4(2):36. doi:10.3390/geriatrics4020036
   PubMed Web of Science ®Google Scholar
• Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet. 2015;386(9997):995–1007. doi:10.1016/S0140-6736(15)60454-8
   PubMed Web of Science ®Google Scholar
• Chan-Yeung M, Xu RH. SARS: epidemiology. Respirology. 2003;8(Suppl):S9–S14. doi:10.1046/j.1440-1843.2003.00518.x
   PubMed Web of Science ®Google Scholar
• Wastesson JW, Morin L, Tan ECK, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opin Drug Saf. 2018;17(12):1185–1196. doi:10.1080/14740338.2018.1546841
   PubMed Web of Science ®Google Scholar
• Mahase E. China coronavirus: what do we know so far? BMJ. 2020;368:m308. doi:10.1136/bmj.m308
   PubMed Web of Science ®Google Scholar
• Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179–186. doi:10.1001/jama.289.2.179
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020:e201585. doi:10.1001/jama.2020.1585.
   Web of Science ®Google Scholar
• Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol. 2020;92(4):441–447. doi:10.1002/jmv.25689
   PubMed Web of Science ®Google Scholar
• Aron J, Muellbauer J A pandemic primer on excess mortality statistics and their comparability across countries. Our World in Data; 2020. Available from https://ourworldindata.org/covid-excess-mortality. [Accessed July 11, 2020.]
   Google Scholar
• Coronavirus Disease 2019 (COVID-19). Daily Data Summary; 2020. Available from https://www1.nyc.gov/assets/doh/downloads/pdf/imm/covid-19-daily-data-summary-deaths-05132020-1.pdf. [Accessed July 11, 2020.]
   Google Scholar
• World Health Organization. Global Health and Aging. Geneva: WHO; 2011. Available athttps://www.who.int/ageing/publications/global_health.pdf?ua=1. Accessed 21 June 2020.
   Google Scholar
• Rich MW. Heart failure in the 21st century: a cardiogeriatric syndrome. J Gerontol a Biol Sci Med Sci. 2001;56(2):M88‐M96. doi:10.1093/gerona/56.2.m88
   PubMed Web of Science ®Google Scholar
• Boumendil A, Maury E, Reinhard I, Luquel L, Offenstadt G, Guidet B. Prognosis of patients aged 80 years and over admitted in medical intensive care unit. Intensive Care Med. 2004;30(4):647‐54. doi:10.1007/s00134-003-2150-z
   PubMed Web of Science ®Google Scholar
• Chiatti C, Bustacchini S, Furneri G, et al. The economic burden of inappropriate drug prescribing, lack of adherence and compliance, adverse drug events in older people: a systematic review. Drug Saf. 2012;35(Suppl 1):73–87. doi:10.1007/BF03319105
   PubMed Web of Science ®Google Scholar
• Back DJ, Marzolini C. The challenge of HIV treatment in an era of polypharmacy. J Int AIDS Soc. 2020;23:e25449. doi:10.1002/jia2.25449
   PubMed Web of Science ®Google Scholar
• Al Ameri MN, Makramalla E, Albur U, Kumar A, Rao P. Prevalence of polypharmacy in the elderly: implications of age, gender, co-morbidities, and drug interactions. SOJ Pharm Sci. 2014;1(3):1–7.
   Google Scholar
• Fukuba N, Nishida M, Hayashi M, et al. The relationship between polypharmacy and hospital-stay duration: a retrospective study. Cureus. 2020;12(3):e7267. doi:10.7759/cureus.7267
   PubMed Web of Science ®Google Scholar
• Back D, Marzolini C, Hodge C, et al. COVID-19 treatment in patients with co-morbidities: awareness of drug-drug interactions. Br J Clin Pharmacol. 2020. doi:10.1111/bcp.14358
   Web of Science ®Google Scholar
• Hung IF, Zhang AJ, To KK, et al. Unexpectedly higher morbidity and mortality of hospitalized elderly patients associated with rhinovirus compared with influenza virus respiratory tract infection. Int J Mol Sci. 2017;18(2):259. doi:10.3390/ijms18020259
   PubMed Web of Science ®Google Scholar
• Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352(17):1749‐59. doi:10.1056/NEJMoa043951
   PubMed Web of Science ®Google Scholar
• Elliot AJ, Fleming DM. Influenza and respiratory syncytial virus in the elderly. Expert Rev Vaccines. 2008;7(2):249‐58. doi:10.1586/14760584.7.2.249
   PubMed Web of Science ®Google Scholar
• Clayville LR. Influenza update: a review of currently available vaccines. P T. 2011;36(10):659‐84.
   Google Scholar
• Goel MK, Goel M, Khanna P, Mittal K. Pandemic influenza A (H1N1) 2009 vaccine: an update. Indian J Med Microbiol. 2011;29(1):13‐18. doi:10.4103/0255-0857.76517
   PubMed Web of Science ®Google Scholar
• Center for Disease Control and Prevention. People 65 years and older & influenzas. National Center for Immunization and Respiratory Diseases (NCIRD); 2019. Available from: https://www.cdc.gov/flu/highrisk/65over.htm. (Accessed May 15, 2020.)
   Google Scholar
• Haber N, Khelili D, Martineau D, Dekimeche S, Szekely C, Lebon P. Delay in diagnosis of influenza virus in an elderly hospitalized patient: a fatal outcome. Clin Med Insights Case Rep. 2012;5:5‐8. doi:10.4137/CCRep.S8460
   PubMedGoogle Scholar
• Régis C, Voirin N, Escuret V, et al. Five years of hospital-based surveillance of influenza-like illness and influenza in a short-stay geriatric unit. BMC Res Notes. 2014;7:99. doi:10.1186/1756-0500-7-99
   PubMedGoogle Scholar
• Ison MG. Influenza in hospitalized adults: gaining insight into a significant problem. J Infect Dis. 2009;200(4):485‐88. doi:10.1086/600384
   PubMed Web of Science ®Google Scholar
• van den Dool C, Hak E, Wallinga J, van Loon AM, Lammers JW, Bonten MJ. Symptoms of influenza virus infection in hospitalized patients. Infect Control Hosp Epidemiol. 2008;29(4):314‐19. doi:10.1086/529211
   PubMed Web of Science ®Google Scholar
• Fried TR, Vaz Fragoso CA, Rabow MW. Caring for the older person with chronic obstructive pulmonary disease. JAMA. 2012;308(12):1254‐63. doi:10.1001/jama.2012.12422
   Web of Science ®Google Scholar
• Wilhelm M. Influenza in older patients: a call to action and recent updates for vaccinations. Am J Manag Care. 2018;24(2 Suppl):S15‐S24.
   PubMed Web of Science ®Google Scholar
• Brundage JF, Shanks GD. Deaths from bacterial pneumonia during 191819 influenza pandemic. Emerg Infect Dis. 2008;14(8):1193‐99. doi:10.3201/eid1408.071313
   PubMed Web of Science ®Google Scholar
• Shanks GD, Mackenzie A, McLaughlin R, et al. Mortality risk factors during the 191819 influenza pandemic in the Australian army. J Infect Dis. 2010;201(12):1880‐9. doi:10.1086/652868
   PubMed Web of Science ®Google Scholar
• Zhou H, Thompson WW, Viboud CG, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 19932008. Clin Infect Dis. 2012;54(10):1427‐36. doi:10.1093/cid/cis211
   Web of Science ®Google Scholar
• Palekar RS, Rolfes MA, Arriola CS, et al. Burden of influenza-associated respiratory hospitalizations in the Americas, 20102015. PLoS One. 2019;14(9):e0221479. doi:10.1371/journal.pone.0221479
   PubMed Web of Science ®Google Scholar
• Amawi H, Abu Deiab GI, An Aljabali AA. COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics, and potential vaccines and therapeutics.. Ther Deliv. 2020;11((4)):245‐68. doi:10.4155
   PubMed Web of Science ®Google Scholar
• Center for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19), people who are at higher risk: older Adults. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/older-adults.html. (Accessed June 21, 2020.)
   Google Scholar
• Bonanad C, García-Blas S, Tarazona-Santabalbina FJ, et al. Coronavirus: la emergencia geriátrica de 2020. Documento conjunto de la sección de cardiología geriátrica de la sociedad española de cardiología y la sociedad española de geriatría y gerontología [coronavirus: the geriatric emergency of 2020. Joint document of the geriatric cardiology section of the spanish society of cardiology and the spanish society of geriatrics and gerontology]. Rev Esp Cardiol. 2020. doi:10.1016/j.recesp.2020.03.027
   Web of Science ®Google Scholar
• Li W, Ding C, Yin S. Severe pneumonia in the elderly: a multivariate analysis of risk factors. Int J Clin Exp Med. 2015;8(8):12463‐75.
   Web of Science ®Google Scholar
• Simonetti AF, Viasus D, Garcia-Vidal C, Carratalà J. Management of community-acquired pneumonia in older adults. Ther Adv Infect Dis. 2014;2(1):3‐16. doi:10.1177/2049936113518041
   PubMedGoogle Scholar
• World Health Organization. Regional office for the western pacific. Calibrating long-term non-pharmaceutical interventions for COVID-19: principles and facilitation tools. Manila: WHO. Regional Office for the Western Pacific; (‎2020)‎. Available from: https://apps.who.int/iris/handle/10665/332099. License: CC BY-NC-SA 3.0 IGO. (Accessed June 21, 2020.)
   Google Scholar
• Hamid S, Mir MY, Rohela GK. Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis, and potential therapeutics). New Microbes New Infect. 2020;35:100679. doi:10.1016/j.nmni.2020.100679
   PubMed Web of Science ®Google Scholar
• World Health Organization. Regional Office for Europe. Statement- Older people are at higher risk from COVID-19, but all must act to prevent community spread; 2020. Avaialablr from:. https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/statements/statement-older-people-are-at-highest-risk-from-covid-19,-but-all-must-act-to-prevent-community-spread.
   Google Scholar
• Fischer F, Raiber L, Boscher C, Winter MH. COVID-19 and the elderly: who cares? Front Public Health. 2020;8:151. doi:10.3389/fpubh.2020.00151
   PubMed Web of Science ®Google Scholar
• Koff WC, Williams MA. Covid-19 and immunity in aging populations - a new research agenda. N Engl J Med. 2020;383:804–805. doi:10.1056/NEJMp2006761
   PubMed Web of Science ®Google Scholar
• Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547. doi:10.1183/13993003.00547-2020
   PubMed Web of Science ®Google Scholar
• Li X, Ma X. Acute respiratory failure in COVID-19: is it “typical” ARDS? Crit Care. 2020;24(198). doi:10.1186/s13054-020-02911-9
   Web of Science ®Google Scholar
• Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846‐8. doi:10.1007/s00134-020-05991-x
   Web of Science ®Google Scholar
• Singhal TA. Review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr. 2020;87(4):281‐6. doi:10.1007/s12098-020-03263-6
   Web of Science ®Google Scholar
• Greenland JR, Michelow MD, Wang L, London MJ. COVID-19 Infection: implications for perioperative and critical care physicians. Anesthesiology. 2020;132(6):1346‐61. doi:10.1097/ALN.0000000000003303
   PubMed Web of Science ®Google Scholar
• Iyengar K, Bahl S, Vaishya R, Vaish A. Challenges and solutions in meeting up the urgent requirement of ventilators for COVID-19 patients. Diabetes Metab Syndr. 2020;14(4):499–501. doi:10.1016/j.dsx.2020.04.048.
   PubMed Web of Science ®Google Scholar
• Mora Carpio AL, Mora JI Ventilator Management. [Updated 2020 Mar 28.]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan. Available at https://www.ncbi.nlm.nih.gov/books/NBK448186. [Accessed May 15, 2020.]
   Google Scholar
• Langer T, Santini A, Bottino N, et al. “Awake” extracorporeal membrane oxygenation (ECMO): pathophysiology, technical considerations, and clinical pioneering. Crit Care. 2016;20(1):150. doi:10.1186/s13054-016-1329-y
   PubMed Web of Science ®Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, co-morbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323(20):2052–2059. doi:10.1001/jama.2020.6775
   PubMed Web of Science ®Google Scholar
• Mert E, Arzu T, Balam YB, Murat A. Infections in the elderly critically ill patients. Frontiers Medicine. 2019;6:118. doi:10.3389/fmed.2019.00118
   Web of Science ®Google Scholar
• World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim Guidance; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf. (Accessed June 21, 2020.)
   Google Scholar
• Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19, and multi-organ response. Curr Probl Cardiol. 2020;45:100618. doi:10.1016/j.cpcardiol.2020.100618
   PubMed Web of Science ®Google Scholar
• Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20(5):269‐70. doi:10.1038/s41577-020-0308-3
   PubMed Web of Science ®Google Scholar
• Corona Tracker Community Research Group. Corona tracker: worldwide COVID-19 outbreak data analysis and prediction. WHO; 2020. Available from: https://www.who.int/bulletin/online_first/20-255695.pdf. (Accessed May 15, 2020.)
   Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054‐62. doi:10.1016/S0140-6736(20)30566-3
   Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708‐20. doi:10.1056/NEJMoa2002032
   Web of Science ®Google Scholar
• Ranieri VM, Rubenfeld GD, et al.; ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526–2533. doi:10.1001/jama.2012.5669.
   PubMed Web of Science ®Google Scholar
• Sommerstein R. Preventing a COVID-19 pandemic. BMJ. 2020;368:m810.
   PubMed Web of Science ®Google Scholar
• Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8:e21. doi:10.1016/S2213-2600(20)30116-8
   PubMed Web of Science ®Google Scholar
• Yang J, Zheng Y, Gou X, et al. Prevalence of co-morbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–95. doi:10.1016/j.ijid.2020.03.01
   PubMed Web of Science ®Google Scholar
• Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcome of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323(16):1674–1681. doi:10.1001/jama.2020.5394
   PubMed Web of Science ®Google Scholar
• Garg S, Kim L, Whitaker M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 – COVID-NET, 14 States, March 1–30. MMWR Morb Mortal Wkly Rep. 2020;69(15):458–464. doi:10.15585/mmwr.mm6915e3
   PubMed Web of Science ®Google Scholar
• Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from wuhan: an analysis based on decade-long structural studies of SARS Coronavirus. J Virol. 2020;94(7):e00127–20. doi:10.1128/JVI.00127-20
   PubMed Web of Science ®Google Scholar
• Cell Editorial Team. Embracing the Landscape of Therapeutics. Cell. 2020 Apr 2;181(1):1-3. doi:10.1016/j.cell.2020.03.025
   Google Scholar
• De Abajo FJ, Rodríguez-Martín S, Lerma V, et al. Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study. Lancet. 2020;395(10238):1705‐14. doi:10.1016/S0140-6736(20)31030-8
   PubMed Web of Science ®Google Scholar
• Schiffrin EL, Flack JM, Ito S, Muntner P, Webb RC. Hypertension and COVID-19. Am J Hypertens. 2020;33(5):373‐4. doi:10.1093/ajh/hpaa057
   Web of Science ®Google Scholar
• Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003;26(2):510–513. doi:10.2337/diacare.26.2.510
   PubMed Web of Science ®Google Scholar
• Muller LM, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. 2005;41(3):281–288. doi:10.1086/431587
   PubMed Web of Science ®Google Scholar
• Yang JK, Feng Y, Yuan MY. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med. 2006;23(6):623–628. doi:10.1111/j.1464-5491.2006.01861.x
   PubMed Web of Science ®Google Scholar
• Alqahtani FY, Aleanizy FS, Ali El Hadi Mohamed R, et al. Prevalence of co-morbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study. Epidemiol Infect. 2018;147::1–5. doi:10.1017/S0950268818002923
   Web of Science ®Google Scholar
• Cariou B, Hadjadj S, Wargny M, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020:1‐16. doi:10.1007/s00125-020-05180-x.
   Web of Science ®Google Scholar
• Jung YJ, Yoon JL, Kim HS, Lee AY, Kim MY, Cho JJ. Atypical clinical presentation of geriatric syndrome in elderly patients with pneumonia or coronary artery disease. Ann of Geri Med and Res. 2017;21(4):158–163. doi:10.4235/agmr.2017.21.4.158
   Google Scholar
• D’Adamo H, Yoshikawa T, Ouslander JG. Coronavirus disease 2019 in geriatrics and long-term care: the ABCDs of COVID-19. J Am Geriatr Soc. 2020;68(5):912–917. doi:10.1111/jgs.16445
   PubMed Web of Science ®Google Scholar
• Holroyd-Leduc J, Gandell D, Alana Miller A, Dmitriy Petrov D. COVID-19 in Older Adults. University of Toronto; 2020. Available from https://www.rgptoronto.ca/wp-content/uploads/2020/04/COVID-19-Presentations-in-Frail-Older-Adults-U-of-C-and-U-fo-T.pdf. (Accessed July 19, 2020.)
   Google Scholar
• Malone ML, Hogan TM, Perry A, et al. COVID-19 in older adults: key points for emergency department providers. J Geri Emerg Med. 2020;1(4):1–11.
   Google Scholar
• Greenhalgh T, Koh GCH, Car J. Covid-19: a remote assessment in primary care. BMJ. 2020;368:m1182. doi:10.1136/bmj.m1182
   PubMed Web of Science ®Google Scholar
• World Health Organization. Strengthening the health system response to covid-19 preventing and managing the Covid-19 pandemic across long-term care services in the WHO. European Region; 2020. Available from https://apps.who.int/iris/bitstream/handle/10665/333067/WHO-EURO-2020-804-40539-54460-eng.pdf?sequence=1&isAllowed=y. (Accessed July 19, 2020.)
   Google Scholar
• Mair A, Fernandez-Llimos F, Alonso A, et al. The sympathy consortium. Polypharmacy management by 2030: a patient safety challenge. Coimbra: SYMPATHY Consortium. 2017.
   Google Scholar
• Mlodinow SG, Linn BS, Mahvan T, Ramer LN, Ngaima NM. Strategies to reduce and prevent polypharmacy in older patients. J Fam Pract. 2019;68(8):429‐40.
   PubMed Web of Science ®Google Scholar
• Dwyer LL, Han B, Woodwell DA, Rechtsteiner EA. Polypharmacy in nursing home residents in the United States: results of the 2004 national nursing home survey. Am J Geriatr Pharmacother. 2010;8(1):63‐72. doi:10.1016/j.amjopharm.2010.01.001
   PubMedGoogle Scholar
• Cooper JA, Cadogan CA, Patterson SM, et al. Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review. BMJ Open. 2015;5(12):e009235. doi:10.1136/bmjopen-2015-009235
   PubMed Web of Science ®Google Scholar
• World Health Organization. Regional strategy for patient-safety in the WHO South-East Asia Region; (2016–2025). Available from: https://apps.who.int/iris/bitstream/handle/10665/205839/B5215.pdf?sequence=1. (Accessed June 21, 2020.)
   Google Scholar
• World Health Organization. Medication safety in polypharmacy. Available from: https://apps.who.int/iris/bitstream/handle/10665/325454/WHO-UHC-SDS-2019.11-eng.pdf?sequence=1&isAllowed=y. (Accessed June 21, 2020.)
   Google Scholar
• World Health Organization (WHO). Medication Without Harm - Global Patient Safety Challenge on Medication Safety. Geneva: World Health Organization; 2017.
   Google Scholar
• Yang J, Liao Y, Lin W-B, et al. Prescribing errors in electronic prescriptions for outpatients intercepted by pharmacists and the impact of prescribing workload on error rate in a Chinese tertiary-care women and children’s hospital. BMC Health Serv Res. 2019;19:1013. doi:10.1186/s12913-019-4843-1
   PubMed Web of Science ®Google Scholar
• Avery A, Barber N, Ghaleb M, et al. Investigating the prevalence and causes of prescribing errors in general practice: the PRACtICe study. London: General Medical Council. 2012;227p.
   Google Scholar
• Sears K, Scobie A, Mackinnon NJ. Patient-related risk factors for self-reported medication errors in hospital and community settings in 8 countries. Can Pharm J. 2012;145(2):88–93. doi:10.3821/145.2.cpj88
   Google Scholar
• Sabzwari SR, Qidwai W, Bhanji S. Polypharmacy in elderly: a cautious trail to tread. J Pak Med Assoc. 2013;63(5):624‐27.
   PubMed Web of Science ®Google Scholar
• Arnoldo L, Cattani G, Cojutti P, Pea F, Brusaferro S. Monitoring polypharmacy in healthcare systems through a multi-setting survey: should we put more attention on long term care facilities? J Public Health Res. 2016;5(3):745. doi:10.4081/jphr.2016.745
   PubMedGoogle Scholar
• Duncan P, Duerden M, Payne RA. Deprescribing: a primary care perspective. Eur J Hosp Pharm. 2017;24(1):37–42. doi:10.1136/ejhpharm-2016-000967
   PubMedGoogle Scholar
• Ross SB, Wilson MG, Papillon‐Ferland L, et al. COVID-SAFER deprescribing guidance for hydroxychloroquine drug interactions in older adults. J Am Geriatr Soc. 2020;68:1636–1646. doi:10.1111/jgs.1662.;.
   PubMed Web of Science ®Google Scholar
• Prybys KM, Melville KA, Hanna JR Polypharmacy in the elderly: clinical challenges in emergency practice. Part i: overview, etiology, and drug interactions. Available from: https://www.reliasmedia.com/articles/119992-polypharmacy-in-the-elderly-clinical-challenges-in-emergency-practice-part-i. (Accessed June 21, 2020).
   Google Scholar
• McDonald VM, Simpson JL, Higgins I, Gibson PG. Multidimensional assessment of older people with asthma and COPD: clinical management and health status. Age Ageing. 2011;40(1):42‐9. doi:10.1093/ageing/afq134
   Web of Science ®Google Scholar
• World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf. (Accessed June 21, 2020.)
   Google Scholar
• Smith PF, Dodds M, Bentley D, Yeo K. Dosing will be a key success factor in repurposing antivirals for COVID-19. Br J Clin Pharmacol. 2020. doi:10.1111/bcp.14314
   Web of Science ®Google Scholar
• Reeve E, Moriarty F, Nahas R, Turner JP, O’Donnell LK, Hilmer SN. A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms. Expert Opin Drug Saf. 2018;17(1):39–49. doi:10.1080/14740338.2018.1397625
   PubMed Web of Science ®Google Scholar
• Vande Griend JP Common Polypharmacy Pitfalls. Pharmacy Times; 2009. Available from: https://www.pharmacytimes.com/publications/issue/2009/2009-01/2009-01-9968. (Accessed May 16, 2020).
   Google Scholar
• Sarwar MR, Iftikhar S, Sarfraz M. Influence of education level of older patients on polypharmacy, potentially inappropriate medications listed in beer’s criteria, and unplanned hospitalization: a cross-sectional study in Lahore, Pakistan. Medicina. 2018;54(4):57. doi:10.3390/medicina54040057
   PubMed Web of Science ®Google Scholar
• Woodward M. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res. 2003;33:323–328. doi:10.1002/jppr2003334323
   Google Scholar
• Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254–1268. doi:10.1111/bcp.12732
   PubMed Web of Science ®Google Scholar
• Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365(21):2002–2012. doi:10.1056/NEJMsa1103053
   PubMed Web of Science ®Google Scholar
• Bennett A, Gnjidic D, Gillett M, et al. Prevalence and impact of fall-risk-increasing drugs, polypharmacy, and drug-drug interactions in robust versus frail hospitalised falls patients: a prospective cohort study. Drugs Aging. 2014;31(3):225–232. doi:10.1007/s40266-013-0151-3
   PubMed Web of Science ®Google Scholar
• Zechmann S, Trueb C, Valeri F, Streit S, Senn O, Neuner-Jehle S. Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland. BMC Fam Pract. 2019;20(1):64. doi:10.1186/s12875-019-0953-4
   PubMed Web of Science ®Google Scholar
• Lavan AH, Gallagher P. Predicting risk of adverse drug reactions in older adults. Ther Adv Drug Saf. 2016;7(1):11–22. doi:10.1177/2042098615615472
   PubMed Web of Science ®Google Scholar
• Stevenson JM, Williams JL, Burnham TG, et al. Predicting adverse drug reactions in older adults; a systematic review of the risk prediction models. Clin Interv Aging. 2014;9:1581–1593. doi:10.2147/CIA.S65475
   PubMed Web of Science ®Google Scholar
• Thompson W, Lundby C, Graabaek T, et al. Tools for deprescribing in frail older persons and those with limited life expectancy: a systematic review. J Am Geriatr Soc. 2019;67(1):172–180. doi:10.1111/jgs.15616
   PubMed Web of Science ®Google Scholar
• American geriatrics society 2012 beers criteria update expert panel. American geriatrics society updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–631. doi:10.1111/j.1532-5415.2012.03923.x
   PubMed Web of Science ®Google Scholar
• Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (screening tool of older person’s prescriptions) and start (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83. doi:10.5414/cpp46072
   PubMed Web of Science ®Google Scholar
• Naugler CT, Brymer C, Stolee P, Arcese ZA. Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol. 2000;7(2):103–107.
   PubMedGoogle Scholar
• McLeod PJ, Huang AR, Tamblyn RM, Gayton DC. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ. 1997;156(3):385–391.
   PubMed Web of Science ®Google Scholar
• Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45(10):1045–1051. doi:10.1016/0895-4356(92)90144-c
   PubMed Web of Science ®Google Scholar
• Wehling M. Multimorbidity and polypharmacy: how to reduce the harmful drug load and yet add needed drugs in the elderly? Proposal of a new drug classification: fit for the aged. J Am Geriatr Soc. 2009;57(3):560–561. doi:10.1111/j.1532-5415.2009.02131.x
   PubMed Web of Science ®Google Scholar
• Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107(3132):543–551. doi:10.3238/arztebl.2010.0543
   PubMed Web of Science ®Google Scholar
• Patterson SM, Cadogan CA, Kerse N, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2014;10:CD008165. doi:10.1002/14651858.CD008165.pub3
   PubMed Web of Science ®Google Scholar
• Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167(8):781–787. doi:10.1001/archinte.167.8.781
   PubMedGoogle Scholar
• Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008;168(5):508–513. doi:10.1001/archinternmed.2007.106
   PubMedGoogle Scholar
• Lowry E, Woodman RJ, Soiza RL, Mangoni AA. Associations between the anticholinergic risk scale score and physical function: potential implications for adverse outcomes in older hospitalized patients. J Am Med Dir Assoc. 2011;12(8):565–572. doi:10.1016/j.jamda.2011.03.006
   PubMed Web of Science ®Google Scholar
• Lowry E, Woodman RJ, Soiza RL, Hilmer SN, Mangoni AA. Drug burden index, physical function, and adverse outcomes in older hospitalized patients. J Clin Pharmacol. 2012;52(10):1584–1591. doi:10.1177/0091270011421489
   PubMed Web of Science ®Google Scholar
• Scott I, Anderson K, Freeman C. Review of structured guides for deprescribing. Eur J Hosp Pharm. 2017;24(1):51–57. doi:10.1136/ejhpharm-2015-000864
   PubMedGoogle Scholar
• Onder G, Petrovic M, Tangiisuran B, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med. 2010;170(13):1142–1148. doi:10.1001/archinternmed.2010.153
   PubMedGoogle Scholar
• Saedder EA, Lisby M, Nielsen LP, et al. Detection of patients at high risk of medication errors: development and validation of an algorithm. Basic Clin Pharmacol Toxicol. 2016;118(2):143–149. doi:10.1111/bcpt.12473
   PubMed Web of Science ®Google Scholar
• Urbina O, Ferrández O, Grau S, et al. Design of a score to identify hospitalized patients at risk of drug-related problems. Pharmacoepidemiol Drug Saf. 2014;23(9):923–932. doi:10.1002/pds.3634
   PubMed Web of Science ®Google Scholar
• Sakuma M, Bates DW, Morimoto T. Clinical prediction rule to identify high-risk inpatients for adverse drug events: the JADE Study. Pharmacoepidemiol Drug Saf. 2012;21(11):1221–1226. doi:10.1002/pds.3331
   PubMed Web of Science ®Google Scholar
• Cook CE. Potential pitfalls of clinical prediction rules. J Man Manip Ther. 2008;16(2):69–71. doi:10.1179/106698108790818477
   PubMedGoogle Scholar
• Iyer S, Goss E, Browder C, Paccione G, Arnsten J. Development and evaluation of a clinical reasoning curriculum as part of an internal medicine residency program. Diagnosis. 2019;6(2):115–119. doi:10.1515/dx-2018-0093
   Web of Science ®Google Scholar
• McGinn T, Jervis R, Wisnivesky J, Keitz S, Wyer PC. Evidence-based Medicine Teaching Tips Working Group. Tips for teachers of evidence-based medicine: clinical prediction rules (CPRs) and estimating pretest probability. J Gen Intern Med. 2008;23(8):1261–1268. doi:10.1007/s11606-008-0623-z
   PubMed Web of Science ®Google Scholar
• Lindsay J, Dooley M, Martin J, et al. The development and evaluation of an oncological palliative care deprescribing guideline: the ‘OncPal deprescribing guideline’. Support Care Cancer. 2015;23(1):71–78. doi:10.1007/s00520-014-2322-0
   PubMed Web of Science ®Google Scholar
• Reeve E, Gnjidic D, Hilmer S. The role of the OncPal deprescribing guideline in end-of-life care. Support Care Cancer. 2015;23(4):899. doi:10.1007/s00520-014-2445-3
   PubMed Web of Science ®Google Scholar
• Bjerre LM, Farrell B, Hogel M, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: evidence-based clinical practice guideline. Can Fam Physician. 2018;64(1):17–27.
   PubMed Web of Science ®Google Scholar
• Thillainadesan J, Gnjidic D, Green S, Hilmer SN. Impact of deprescribing interventions in older hospitalised patients on prescribing and clinical outcomes: a systematic review of randomised trials. Drugs Aging. 2018;35(4):303–319. doi:10.1007/s40266-018-0536-4
   PubMed Web of Science ®Google Scholar
• Payne RA, Avery AJ. Polypharmacy: one of the greatest prescribing challenges in general practice. Br J Gen Pract. 2011;61(583):83–84. doi:10.3399/bjgp11X556146
   PubMed Web of Science ®Google Scholar
• Khezrian M, McNeil CJ, Murray AD, Myint PK. An overview of prevalence, determinants and health outcomes of polypharmacy. Ther Adv Drug Saf. 2020;11:2042098620933741. doi:10.1177/2042098620933741
   Web of Science ®Google Scholar
• World Health Organization. Medication safety in polypharmacy. Technical Report; 2019. (WHO/UHC/SDS/2019.11). License: CC BY-NC-SA 3.0 IGO. Available from: https://apps.who.int/iris/rest/bitstreams/1235792/retrieve. (Accessed May 16, 2020.)
   Google Scholar
• Cadogan CA, Ryan C, Hughes CM. Appropriate polypharmacy and medicine safety: when many is not too many. Drug Safety. 2016;39(2):109–116. doi:10.1007/s40264-015-0378-5
   PubMed Web of Science ®Google Scholar
• Rochon PA Drug prescribing for older adults. Available from: https://www.uptodate.com/contents/drug-prescribing-for-older-adults. (Accessed June 21, 2020.)
   Google Scholar
• Wilfling D, Hinz A, Steinhäuser J. Big data analysis techniques to address polypharmacy in patients - a scoping review. BMC Fam Pract. 2020;21(1):180. doi:10.1186/s12875-020-01247-1
   PubMed Web of Science ®Google Scholar
• Ailabouni NJ, Hilmer SN, Kalisch L, Braund R, Reeve E. COVID-19 pandemic: considerations for safe medication use in older adults with multimorbidity and polypharmacy. J Gerontol. doi:10.1093/gerona/glaa104
   Google Scholar
• SYMPATHY project: innovation for appropriate polypharmacy in the elderly. In: Digital Single Market [Website]. Brussels: European Commission. 2016. Available at: (https://ec.europa.eu/digital-singlemarket/en/news/simpathy-project-innovationappropriate-polypharmacy-elderly.) (accessed 21 June 2020.)
   Google Scholar
• Wilson M, Mair A, Dreischulte T, Witham M. Prescribing to fit the needs of older people: the NHS Scotland Polypharmacy Guidance, 2nd edition. J R Coll Physicians Edinb. 2015;45(2):108–113. doi:10.4997/JRCPE.2015.204
   PubMed Web of Science ®Google Scholar
• World Health Organization. Advice on the use of masks in the community, during home care and in health care settings in the context of the novel coronavirus (2019‐nCoV) outbreak: Interim Guidance; 2020. Available from: https://www.who.int/docs/default-source/documents/advice-on-the-use-of-masks-2019-ncov.pdf. (Accessed June 21, 2020.)
   Google Scholar
• Centers for Disease Control and Prevention. 2019‐nCoV: prevention & Treatment; 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/about/prevention-treatment.html. (Accessed June 21, 2020.)
   Google Scholar
• Haque M, Islam T, Rahman NAA, McKimm J, Abdullah A, Dhingra S. Strengthening Primary Health-Care Services to Help Prevent and Control Long-Term (Chronic) Non-Communicable Diseases in Low- and Middle-Income Countries. Risk Manag Healthc Policy. 2020;13:409-426. doi:10.2147/RMHP.S239074
   Google Scholar
• Lim WH, Wong WM. COVID-19: notes from the front line, singapore’s primary health care perspective. Ann Fam Med. 2020;18(3):259–261. doi:10.1370/afm.2539
   PubMed Web of Science ®Google Scholar
• Lee VJ, Chiew CJ, Khong WX. Interrupting transmission of COVID-19: lessons from containment efforts in Singapore. J Travel Med. 2020;27(3):taaa039. doi:10.1093/jtm/taaa039
   PubMed Web of Science ®Google Scholar
• Paudel S, Dangal G, Chalise A, Bhandari TR, Dangal O. The coronavirus pandemic: what does the evidence show? J Nepal Health Res Counc. 2020;18(1):1–9. doi:10.33314/jnhrc.v18i1.2596
   PubMedGoogle Scholar
• Qian X, Ren R, Wang Y, et al. Fighting against the common enemy of COVID-19: a practice of building a community with a shared future for mankind. Infect Dis Poverty. 2020;9(1):34. doi:10.1186/s40249-020-00650-1
   PubMed Web of Science ®Google Scholar
• Chang BB, Chiu TY. Ready for a long fight against the COVID-19 outbreak: an innovative model of tiered primary health care in Taiwan. BJGP Open. 2020;4(2):bjgpopen20X101068. doi:10.3399/bjgpopen20X101068
   PubMedGoogle Scholar
• Lin C, Braund WE, Auerbach J, et al. Policy decisions and use of information technology to fight COVID-19, Taiwan. Emerg Infect Dis. 2020;26(7):1506–1512. doi:10.3201/eid2607.200574
   PubMed Web of Science ®Google Scholar
• Kumar P. How to strengthen primary health care. J Family Med Prim Care. 2016;5(3):543–546. doi:10.4103/2249-4863.197263
   PubMedGoogle Scholar
• Watkins DA, Jamison DT, Mills T, et al. Universal health coverage and essential packages of care. In: Disease Control Priorities: Improving Health and Reducing Poverty. Jamison DT, Gelband H, Horton S, et al., eds. 3rd ed. Washington (DC): The International Bank for Reconstruction and Development/The World Bank; 2017.
   Google Scholar
• Haque M. Combating covid-19: a coordinated efforts of healthcare providers and policy makers with global participation are needed to achieve the desired goals. Bang J Med Sci. 2020;19(Special Issue on Covid19):01–05.
   Google Scholar
• Haque M. The COVID-19 pandemic - a global public health crisis: a brief overview regarding pharmacological interventions. Pesquisa Brasileira Em Odontopediatria e Clínica Integrada. 2020;20(\(Supp1)):e0146. doi:10.1590/pboci.2020.137
   Web of Science ®Google Scholar
• Thomas SL, Wakerman J, Humphreys JS. What core primary health care services should be available to Australians living in rural and remote communities? BMC Fam Pract. 2014;15:143. doi:10.1186/1471-2296-15-143
   PubMed Web of Science ®Google Scholar
• Lyle D, Saurman E, Kirby S, Jones D, Humphreys J, Wakerman J. What do evaluations tell us about implementing new models in rural and remote primary health care? Findings from a narrative analysis of seven service evaluations conducted by an Australian Centre of Research Excellence. Rural Remote Health. 2017;17(3):3926. doi:10.22605/RRH329
   PubMed Web of Science ®Google Scholar